earnings
saveSarepta Therapeutics, Inc. earnings
community read0 votes
Anticipated earnings call for Sarepta Therapeutics, Inc. ($SRPT).
view source ↗Data sources
Found something off?
related news · 4
- biopharma diveEpicrispr lands $90M to advance epigenetic editing drug for rare muscle disease
- biospaceCapricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
- biospaceSarepta names former AbbVie R&D exec Michael Severino as next CEO
- statSTAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
comments(0)
5-min edit window · permanent after that